BHST (BioHarvest Sciences) Forward PE Ratio: 23.89 (As of Jul. 13, 2026)


BHST BioHarvest Sciences Inc BHST
63 GF Score
Price $2.71
GF Value $8.59
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BioHarvest Sciences Forward PE Ratio?

BioHarvest Sciences BHST -2.52% 63 Forward PE Ratio is 23.89 as of Jul. 13, 2026. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.59 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 744 Consumer Packaged Goods companies, BioHarvest Sciences ranks worse than 82.66% on this metric.

BioHarvest Sciences's Forward PE Ratio for today is 23.89.

BioHarvest Sciences's PE Ratio without NRI for today is 0.00.

BioHarvest Sciences's PE Ratio (TTM) for today is 0.00.


BioHarvest Sciences  (NAS:BHST) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


BioHarvest Sciences Forward PE Ratio Related Terms


BioHarvest Sciences Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for BioHarvest Sciences's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences Forward PE Ratio Chart

BioHarvest Sciences Annual Data
Trend 2024-12
Forward PE Ratio
37.73

BioHarvest Sciences Quarterly Data
2024-12 2025-09
Forward PE Ratio 37.73 181.50

BHST vs BRID, BOF, BFNH: Forward PE Ratio Comparison

For the Packaged Foods subindustry, BioHarvest Sciences's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences Forward PE Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Forward PE Ratio falls into.


BHST
63GF Score
BioHarvest Sciences Inc BHST
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioHarvest Sciences Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 23.89 mean?
BioHarvest Sciences (BHST) has a Forward PE Ratio of 23.89 as of Jul. 13, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on BioHarvest Sciences and its competitors. According to the industry distribution chart, BioHarvest Sciences ranks #615 out of 744 companies in the Consumer Packaged Goods industry, placing it in the top 82.7%.
Is BioHarvest Sciences' Forward PE Ratio too high?
BioHarvest Sciences' current Forward PE Ratio is 23.89. The Consumer Packaged Goods industry median Forward PE Ratio is 14.26. BioHarvest Sciences' value of 23.89 is 67.5% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #615 out of 744 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Forward PE Ratio compare to BRID and BOF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #615 out of 744 companies for Forward PE Ratio. This places BioHarvest Sciences in the lower half of its industry. The industry median Forward PE Ratio is 14.26. BioHarvest Sciences' value of 23.89 is 67.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Consumer Packaged Goods company?
The median Forward PE Ratio among Consumer Packaged Goods companies is 14.26, based on 744 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current Forward PE Ratio of 23.89 is 67.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median Forward PE Ratio is 14.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current Forward PE Ratio is 23.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.59, compared to a current price of $2.71 — trading 68.5% below its estimated fair value. The current Forward PE Ratio is 23.89 and 67.5% above the Consumer Packaged Goods industry median of 14.26. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Forward PE Ratio is 23.89 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioHarvest Sciences (BHST) Overvalued in 2026?

Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued. The current stock price of $2.71 is trading 68.5% below its estimated GF Value™ of $8.59. GuruFocus considers BioHarvest Sciences to be Possible Value Trap.

Key valuation signals for BHST:

  • Forward PE Ratio: 23.89
  • GF Value™: $8.59 vs. price of $2.71 (68.5% below fair value)
  • GF Score™: 63/100 with 4 warning signs
  • Industry Position: 67.5% above the Consumer Packaged Goods median (#615 of 744)

No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioHarvest Sciences Business Description

Other Exchanges 8MV0:Germany
Address 1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score

Get the complete analysis for BHST

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.71
Price
$8.59
GF Value